1. Home
  2. NNDM vs GLUE Comparison

NNDM vs GLUE Comparison

Compare NNDM & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNDM
  • GLUE
  • Stock Information
  • Founded
  • NNDM 2012
  • GLUE 2019
  • Country
  • NNDM United States
  • GLUE United States
  • Employees
  • NNDM N/A
  • GLUE N/A
  • Industry
  • NNDM Electrical Products
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNDM Technology
  • GLUE Health Care
  • Exchange
  • NNDM Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • NNDM 334.6M
  • GLUE 351.2M
  • IPO Year
  • NNDM N/A
  • GLUE 2021
  • Fundamental
  • Price
  • NNDM $1.33
  • GLUE $4.38
  • Analyst Decision
  • NNDM
  • GLUE Buy
  • Analyst Count
  • NNDM 0
  • GLUE 2
  • Target Price
  • NNDM N/A
  • GLUE $13.50
  • AVG Volume (30 Days)
  • NNDM 2.7M
  • GLUE 438.2K
  • Earning Date
  • NNDM 08-19-2025
  • GLUE 08-07-2025
  • Dividend Yield
  • NNDM N/A
  • GLUE N/A
  • EPS Growth
  • NNDM N/A
  • GLUE N/A
  • EPS
  • NNDM N/A
  • GLUE 0.29
  • Revenue
  • NNDM $58,812,000.00
  • GLUE $177,986,000.00
  • Revenue This Year
  • NNDM N/A
  • GLUE $49.02
  • Revenue Next Year
  • NNDM N/A
  • GLUE N/A
  • P/E Ratio
  • NNDM N/A
  • GLUE $14.65
  • Revenue Growth
  • NNDM 7.49
  • GLUE 2990.57
  • 52 Week Low
  • NNDM $1.33
  • GLUE $3.50
  • 52 Week High
  • NNDM $2.74
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • NNDM 31.66
  • GLUE 37.05
  • Support Level
  • NNDM $1.37
  • GLUE $4.75
  • Resistance Level
  • NNDM $1.42
  • GLUE $4.98
  • Average True Range (ATR)
  • NNDM 0.06
  • GLUE 0.35
  • MACD
  • NNDM -0.01
  • GLUE -0.17
  • Stochastic Oscillator
  • NNDM 4.55
  • GLUE 13.40

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: